Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity

Journal of Nutrition

Volumn 131, Issue 7, 2001, Pages 2034-2039

  Varilek, Gary W ^a,d   Yang, Fajun ^a   Lee, Eun Y ^a   DeVilliers, Willem J S ^a,b   Zhong, Jian ^a   Oz, Helieh S ^d   Westberry, Kenloch F ^b   McClain, Craig J ^a,c,d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d University of Louisville School of Medicine   (United States)

Author keywords

Alternative medicine; Colitis; Green tea; Inflammation; Mice

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; POLYPHENOL DERIVATIVE; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ACTIVITY; ENTERITIS; HEMATOCRIT; HISTOLOGY; INFLAMMATION; LAMINA PROPRIA; MOUSE; NONHUMAN; ORGAN WEIGHT; PROTEIN DEFICIENCY; SCORING SYSTEM; TEA; WEIGHT GAIN;

EID: 0034933596     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/131.7.2034     Document Type: Article

References (31)

1. Outpatient healthcare utilization of patients with inflammatory bowel disease
2. Relationship between the use of unconventional therapies and disease-related concerns: A study of patients with inflammatory bowel disease
3. Complementary medicine use by patients with inflammatory bowel disease
4. Green tea and cancer in humans: A review of the literature
5. Antimutagenic and anticarcinogenic activity of tea polyphenols
6. Polyphenolic flavonols as scavengers of aqueous phase radicals and as chain-breaking antioxidants
7. Green tea polyphenols block endotoxin-induced tumor necrosis factor production and lethality in a murine model
8. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB
9. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
10. Increased nuclear factor-κB activation in colitis of IL-2 deficient mice
11. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in IL-10-deficient mice
12. Mechanisms of intestinal cell injury and colitis in interleukin 2 (IL-2)-deficient mice
13. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) Th1-like responses
14. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea
15. T cells, but not B cells are required for bowel inflammation in interleukin 2-deficient mice
16. Dysregulated intrathymic development in the IL-2-deficient mouse leads to colitis-inducing thymocytes
17. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice
18. Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation
19. 3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue
20. Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease
21. Neutrophils, nitrogen oxides and inflammatory bowel disease
22. Depleted mucosal antioxidant defenses in inflammatory bowel disease
23. The 21-aminosteroid-tirilazad mesylate can ameliorate inflammatory bowel disease in rats
24. Oral administration of rutoside can ameliorate inflammatory bowel disease in rats
25. Phase II trial of copper zinc superoxide dismutase (CuZn SOD) in the treatment of Crohn's disease
26. Signal transduction through NF-κB
27. The NF-κB and IκB proteins: New discoveries and insights
28. Nuclear factor-κB - A pivotal transcription factor in chronic inflammatory diseases
29. Nuclear factor kappa B is activated in macrophages and epithelial cells of inflamed intestinal mucosa
30. Activation of nuclear factor kappa B in inflammatory bowel disease
31. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates etablished experimental colitis in mice